YESHAYA SHARON sold $2.0M of MS (indirect holdings)

YESHAYA SHARON (Chief Financial Officer) sold 9,172 indirectly-held shares of MORGAN STANLEY (MS) at $222.51 ($2.04M total) on 2026-07-16.

Original reporting
SEC EDGAR · YESHAYA SHARON
Published Jul 17, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 17, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MS
Neutral
medium confidence
Mentioned
$MS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MSNeutralLow
01

Why it matters

This provides a fresh, primary-source datapoint on insider selling activity, but it does not include guidance, legal/regulatory developments, or operational changes.

02

Market read

Traders may monitor for sentiment effects from insider selling, but there is no accompanying fundamental catalyst in the text.

03

What to watch

The filing notes indirect holdings and that post-transaction shares are 0; without context on total beneficial ownership, the signal strength is limited.

Relevance 6/10Novelty 5/10Timing: after-hours filing on 2026-07-17 for a 2026-07-16 sale

Background

The article is a SEC Form 4 insider transaction disclosure for Morgan Stanley’s CFO.

Company-level read

Ticker impact

$MSNeutralMedium confidence
Context

Morgan Stanley CFO Yeshaya Sharon filed a Form 4 selling 9,172 shares at $222.51 for about $2.04M, indirect holdings, no 10b5-1 plan.

Expected impact

Low likelihood of sustained price impact; any effect is likely short-lived unless accompanied by other disclosures.

Evidence & confidence

The filing is a Form 4 open-market sale by the CFO, with no 10b5-1 plan stated. While the transaction size is not trivial, insider sales are often non-informational and the article provides no new company-specific fundamentals.

Market effects

Minimal read-through to the broader financials sector; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could be interpreted as more discretionary selling, but insider sales frequently reflect diversification or tax planning rather than bearish expectations.

Key entities

  • MORGAN STANLEY

    Company whose CFO filed the Form 4 insider sale.

  • YESHAYA SHARON

    Chief Financial Officer reporting an open-market sale of MS shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MSLow

Sally Diffley resigned from her position as Chief Financial Officer of Morgan Stanley Investment Management Inc., the delegated sponsor of Morgan Stanley…

Morgan Stanley Bitcoin Trust (MSBT) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 30, 2026, Sally Diffley resigned from her position as Chief Financial Officer of Morgan Stanley Investment Management Inc., the delegated sponsor (“Delegated Sponsor”) of Morgan Stanley Bitcoin Trust (the “Trust”). Effective November 4, 2026, Sw

$UBSMed

UBS faces $16bn Swiss capital burden as Morgan Stanley merger talk grows

UBS Group AG (UBSG) faces a $16bn capital burden due to Swiss rules, potentially forcing a merger or domicile change. Morgan Stanley (MS) is mentioned as a possible partner, with a potential $138bn deal. UBSG shares are down 0.58%, while MS is up 2.3% in pre-market trade. UBSG's CEO has hinted at considering a domicile change. The Swiss Senate will debate banking rules in December 2026, with UBSG's Q4 2026 results expected to provide clarity on any strategic decisions.

$AVGOHigh

Blackstone and Wall Street Banks Back US$63bn AI Chip Deal

Blackstone, Morgan Stanley, Citi, and Bank of America are providing US$63bn in financing to Anthropic for Broadcom's AI processors and networking equipment. The deal includes US$43.5bn in senior debt and first-lien facilities, with hardware deliveries expected in early 2027. Broadcom offers residual value protection to senior lenders. This follows Anthropic's potential IPO filing amid concerns over deficits and digital safety.

$AVGOMed

Banks Announce $63 Billion Financing Arrangement for Anthropic

Banks including Bank of America, Citi, and Morgan Stanley arranged a $63B financing deal for Anthropic to lease Broadcom equipment. Blackstone committed to part of the second-lien tranche. StoneX maintained a Buy rating on Nvidia, citing AI investment and Broadcom's role in the deal. Anthropic's equipment rent is estimated at $125.2B over five years, with shipments starting in 2027.